Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates ongoing recruitment for an allogeneic hematopoietic stem cell transplantation approach addressing Common Variable Immu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hematopoietic stem cell transplantation (allogeneic) (Allogeneic hematopoietic stem cell transplantation)

Snippet

Sponsor: Paul Szabolcs | Conditions: Common Variable Immunodeficiency (CVID), Primary Immune Regulatory Disorder | Phase 2 | Status: RECRUITING